• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL’s CEO will present perspectives about the future of EMA at the DIA Europe 2021

SFL’s CEO Shayesteh Fürst-Ladani, in her capacity as President of the Medtech & Pharma Platform Association (MPP), will take part in the DIA Europe 2021 Diamond Session on ‘EMA 2030 and beyond – How should the EMA of the future look like – Stakeholder expectations’ on 19 March 2021. She will share MPP’s vision how EMA might develop its role for products combining medicines, medical devices, IVDs and/or tech components.

SFL’s cross-functional team provide strategic and hands-on support for development, registration, certification and lifecycle management of medicinal products, medical devices, in vitro diagnostics and combined products. Find out more on our services or contact us at office@sfl-services.com.

  • News
  • Newsletter

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top